Active Pharmaceutical Ingredient (Generic)

VERICIGUAT

Clinical Profile:

*Chronic heart failure with reduced ejection fraction in patients stabilised after a recent decompensation event requiring intravenous therapy:* Adult: Initially 2.5 mg once daily, dose to be doubled approximately every 2 weeks if tolerated, to maintenance dose; maintenance 10 mg once daily.

Marketed Brands Containing VERICIGUAT (1) Compare Brand Prices
Brand Name Manufacturer / Company Available Pack Sizes & Price Action
VERIZOT 🏢 HORIZON
Tab 2.5 mg 30: Rs.900.00
Tab 5 mg 30: Rs.1200.00
Tab 10 mg 30: Rs.1500.00
View Details →

Related Generics

Other generic formulations in the same therapeutic groups as VERICIGUAT.

SPARSENTAN 1 brand(s)